RespiratoryMedicine(2014)108,453e462
Available onlineat www.sciencedirect.com
ScienceDirect
journal homepage: www.elsevier.com/locate/rmed
A home telehealth program for patients with
severe COPD: The PROMETE study
G. Segrelles Calvo a,*, C. G´omez-Su´arezb, J.B. Soriano c,
E. Zamoraa, A. Go´nzalez-Gamarrad, M. Gonz´alez-Be´jare,
A. Jord´anb, E. Tadeo b, A. Sebasti´an f, G. Fern´andez g,
J. Ancochea a
aPneumology Service, LaPrincesaInstitute forHealth Research (IP),
Hospital Universitario dela Princesa, Madrid, Spain
bLinde Healthcare, TheLinde Group, Spain
cEpidemiology andClinical Research Program,CIMERA,Bunyola, Illes Balears,Spain
dGoya PrimaryCare Center,Spain
eMontesa PrimaryCare Center,Spain
fHospital Universitario dela Princesa, Madrid,Spain
gDepartment ofMedical Research andDocumentation, Hospital Universitario dela Princesa,
Madrid, Spain
Received 21 May2013; accepted 8December 2013
Available online 16December2013
KEYWORDS Summary
Telehealth; Background:Acuteexacerbationsofchronicobstructivepulmonarydisease(AECOP)arekey
Telemedicine; eventsinthenaturalhistoryofthedisease.PatientswithmoreAECOPDhaveworseprognosis.
COPD; ThereisaneedofinnovativemodelsofcareforpatientswithsevereCOPDandfrequentAE-
Comorbidities; COPD,andTelehealth(TH)ispartoftheseprograms.
Elderly; Methods:Inaclusterassignment,controlledtrialstudydesign,werecruited60patients,30in
Hospitalizations hometelehealth(HT)and30inconventionalcare(CC).Allparticipantshadapriordiagnosisof
COPDwithapost-bronchodilatorforcedexpiratoryvolume(FEV )%predicted<50%,age(cid:1)50
1
years,wereonlong-termhome oxygen therapy,andnon-smokers.Patients in theHT group
measuredtheirvitalsignsonadailybases,anddataweretransmittedautomaticallytoaClin-
icalMonitoringCenterforfollowed-up,andwhoescalatedclinicalalertstoaPneumologist.
Results:After7-month of monitoringandfollow-up, therewasasignificantreductionin ER
visits(20 in HT vs.57inCC),hospitalizations(12vs.33),lengthof hospitalstayin (105vs.
276days),andevenneedfornon-invasivemechanicalventilation(0vs.8),allp<0.05.Time
to the first severe AECOPD increased from 77 days in CC to 141 days in HT (K-M p <0.05).
* Correspondingauthor.ServiciodeNeumolog´ıa,HospitalUniversitarioLaPrincesa,c/DiegodeLeo´n62,6(cid:3) planta,28006Madrid,Spain.
E-mailaddress:gsegrelles@hotmail.com(G.SegrellesCalvo).
0954-6111/$-seefrontmatterª2013ElsevierLtd.Allrightsreserved.
http://dx.doi.org/10.1016/j.rmed.2013.12.003
454 G.Segrelles Calvo etal.
Therewasnostudywithdrawalsassociatedwithtechnology.Allpatientsshowedahighlevelof
satisfactionwiththeHTprogram.
Conclusions:WeconcludethatHTinelderly,severeCOPDpatientswithmultiplecomorbidities
issafeandefficaciousinreducinghealthcareresourcesutilization.
ª2013ElsevierLtd.Allrightsreserved.
Abbreviations list IPC informal primary carer
LABA long-acting beta-adrenergic agonists
AECOPD
LAMA long-acting muscarinic antagonist
acuteexacerbationsofchronicobstructive
NIV non-invasive ventilation
pulmonary disease
PEF Peak expiratory flow
CAT COPD Assessment Test
PDE4i phosphodiesterase 4 inhibitor
COPD chronic obstructive pulmonary disease
PCC primary care center
CC conventional care
PROMETE Madrilian Telehealth PROject for COPD
ER emergency room
SD standard deviation
FEV forced expiratory volume in the first
1 SGRQ Saint George Respiratory Questionnaire
second
TH Telehealth
HT home telehealth
CMC Clinical Monitoring Center
HULP Hospital Universitario La Princesa
ICS inhaled cortico-steroids
Introduction patient’s satisfaction, specially in the older and more se-
vere patients [10].
Although TH programs have been developed for COPD
Chronic obstructive pulmonary disease (COPD) is a leading
patients, none has been specifically geared to people who
but under-recognized cause of morbidity and mortality
experience severe airflow obstruction, multiple comorbid-
worldwide. No other disease that is responsible for com-
ities,andlimitationsindailylife.WehypothesizedthatHT
parable burden worldwide is neglected by healthcare pro-
can be a useful strategy for monitoring these patients at
viders as much as COPD [1,2]. COPD is projected to move
the home in a follow-up program that coordinates Primary
from the currently fourth to third position in terms of
andSecondary Care services.
morbidityby2020[3,4].Akeyaspectinthenaturalhistory
The purpose of our study (the PROMETE study, “Madri-
of the disease are episodes of acute exacerbations
lian Telehealth PROject for COPD) was to assess the effi-
(AECOPD). AECOPD are more frequent in patients with
cacy and effectiveness of a home telehealth program for
largerairflowobstructionandahistoryofmoreepisodesin
COPDpatientswithsevereairflowobstructionbymeasuring
the previous year [5]. Moreover patients who suffer the
the number of emergency room visits, hospitalizations,
highestnumbersofAECOPDareconsideredtohaveafaster
length ofhospital stay, andmortality.
disease progression, presence of comorbidities, and worse
functionalprognosis [6].
Research is therefore needed on innovative models of
Material and methods
care for patients with severe COPD and frequent AECOPD,
in order to detect and manage the occurrence of exacer-
bations of AECOPD at an early stage, and hence reduce Study population
their negative effect on the disease progression. The
importance of these programs has been highlighted in the Weconductedanopen-label,controlled,non-blindclinical
National Strategy for COPD of the Spanish National Health trial, coordinarted at the Pneumology Service of the Hos-
System[7].Telehealth(TH)ispartoftheseprograms,asit pitalUniversitarioLaPrincesa(HULP)withthePrimaryCare
allows patients to be monitored in their home, gathering Centres (PCC) in itsareaofinfluence.
useful information that can be used for an early interven- Initially we randomized the PCC customers that
tionshould anAECOPD occur[8]. belongedtoHULPintotwogroups:HTorConventionalCare
Current evidence shows that Home Telehealth (HT) (CC).Patientswererandomizedfollowingatwo-colorcode.
programs can reduce the number and length of stay in All PCC customers were assigned to one or another color
hospital admissions and emergency visits [9]. And Sicotte using an envelope system dividing into two groups by
et al. demonstrated that TH increases empowerment and chance. According to PCC membership patients were
COPDtelemedicine program: PROMETE 455
Table 1 Sociodemographic and clinical characteristics of participants, by randomization to conventional care (CC) or tele-
medicine(TM).
Parameters CC(nZ30) TM(nZ29) p-Value
Male,n(%) 22(73.3) 22(75.9) 1.00
Age(years),mean(cid:4)SD 72.7(cid:4)9.3 75.0(cid:4)9.7 0.357
Educationlevel.n(%) Illiterate 1(3.3) 1(3.4) 0.998
Primary 10(33.3) 10(34.5)
Secondary 10(33.3) 10(34.5)
University 9(30.0) 8(27.6)
Employmentstatus,n(%) Active 2(6.7) 1(3.4) 0.443
Retired 25(83.3) 23(79.3)
Disabled/unable 3(10.0) 5(17.2)
Withcaretaker,n(%) 19(63.3%) 18(62.1%) 1.00
DyspneamMRC,n(%) II 8(26.7) 3(10.3) 0.183
III 17(56.7) 17(58.6)
IV 5(16.7) 9(31.0)
COPDhospitalizationsin 1.9(cid:4)1.4 1.7(cid:4)1.0 0.663
thelastyear,mean(cid:4)SD
COPDhospitalizationsin 1ornone 16(55.2) 16(53.3) 0.548
thelastyear,n(%) 2ormore 13(44.8) 14(46.7)
Mobility,n(%) Bed-armchair 3(10) 0(0.0) 0.201
Withinhome 8(26.7) 10(4.5)
Leaveshome 19(63.3) 19(65.5)
Homestatus,n(%) Alone 5(16.7) 4(13.8) 0.836
Withpartner 18(60.0) 19(65.5)
Withotherrelatives 6(20.0) 4(13.8)
Withcaretaker 1(3.3) 2(6.9)
Barthel,mean(cid:4)SD 84.5(cid:4)15.1 89.3(cid:4)13.7 0.239
Charlson,mean(cid:4)SD 3.4(cid:4)2.1 3.7(cid:4)1.4 0.555
Drugsperday,mean(cid:4)SD 8.3(cid:4)2.8 8.3(cid:4)3.7 0.980
Respiratorymedications,n LAMAþLABAþICCI 23 26 0.95
PDE4inhibitors 6 2 0.103
Mucolythics 12 11 1.000
Theophyllines 3 2 1.000
Oralsteroids 4 1 0.353
Lungfunction,mean(cid:4)SD FEV post-BD 37.1(cid:4)10.8 38.3(cid:4)11.9 0.525
1
BODEX 5.7(cid:4)1.2 5.2(cid:4)1.0 0.125
Homeoxygen,hours/day 20.2(cid:4)4.7 18.6(cid:4)3.8 0.198
HomeoxygenflowinL/minute 2.06(cid:4)0.5 2.04(cid:4)0.4 0.851
Qualityoflifeandother CAT 21.2(cid:4)6.6 18.2(cid:4)7.3 0.771
assessments euroQOl 4.50(cid:4)1.8 5.10(cid:4)2.2 0.396
Goldberganxiety 3.0(cid:4)2.4 3.70(cid:4)2.9 0.203
Goldbergdepression 3.5(cid:4)2.7 3.80(cid:4)2.9 0.468
Parametersmeasuredby Bloodpressure(systolic/ 123(cid:4)14.1/ 130(cid:4)13/ 0.52
homeatelehealth, diastolic;mmHg) 69(cid:4)12.4 80(cid:4)12.1
mean(cid:4)SD Pulsioximetry(%) 92(cid:4)3.1 94(cid:4)1.6 0.17
Heartrate(beatperminute,bpm) 80(cid:4)14.8 76(cid:4)15.2 0.71
Peak-flow(litre/second) 132(cid:4)57.5
LAMA: Long action muscarinic antagonist; LABA: long action beta-adrenergics agonist; ICCI: inhaled cortico-steroids; PDE4 inhibitor:
phosphodiesterasa4inhibitor.
a TheseparameterswerecollectedinthefirstclinicalvisitathomeintheCCgroupandbytelemonitoring(firstday)intheTMgroup.
assigned to each study group (group allocation). Patients economiclevels(Table1),andhenceitisfairtostatethat
referredfromtheGoya,Montesa,LagascaandCastelloPCC all determinantswereequally balancedby study group.
wereassignedto HT,andtherestwereclusterassignment In addition, all patients were followed up at the pneu-
totheCCgroup.Weperformedgrouptreatmentallocation mologyclinicinourhospital,whichalsounifiesthecriteria
by center, one case to one control. All PCC customers formonitoringandtreatmentofrespiratorydisease.When-
shared the same geographic localization (District of Sala- everpatientsfromeithergroupcametotheemergencyroom
manca in Madrid), population characteristic, cultural and (ER), they were evaluated by the Pneumologist in charge,
456 G.Segrelles Calvo etal.
First step: PCC randomization
HOME TELEHEALTH (PCC Goya, CONVENTIONAL CARE (the others PCC)
Montesa, Castelló and Lagasca)
Second step:allocation of patients by PCC
Assessment for eligibility (n=195)
(n=594)
Deceased (n=25)
Refused (n=6)
Excluded (n=70)
Not recruited (n=34)
HOME TELEHEALTH (n=30) CONVENTIONAL CARE (n=30)
Lost to follow-up (n=0) Lost to follow-up (n=0)
Withdrawals (n=2) Withdrawals (n=0)
1 patient backafter two weeks Died (n=4)
Died (n=2)
Completed trial(n=27) Completed trial (n=26)
Analyzed (n=29) Analyzed (n=30)
Figure1 CONSORTflowchartoftrialparticipation.
ergomaintainingasimilarapproachintheassessmentofERs years;4)onlong-termhomeoxygentherapy;5)nocurrent
and deciding whether the patient should be admitted or smoker, at least for the past 6 months, determined by
discharged,independentlyoftheirgroupassignment. measuring carboxyhemoglobin levels in arterial blood gas
Eligible patients were identified if they had been (cid:5)2%. Patients were excluded if: 1) did not meet at least
admitted to any of the following units in our hospital: one of the above criteria; 2) were enrolled in a palliative
Pneumology, Internal Medicine and Infectious Diseases care program for lung or another disease; 3) were institu-
services, with a clinical diagnosis of “COPD exacerbation” tionalized or at risk of social exclusion; 4) were deemed
duringtheperiodfromJanuary1,2010toJuly31,2011.We unable to understand all procedures.
identified a total of 594 patients in the HULP database Both study groups continued with their scheduled med-
system (Fig. 1). icalvisitsduringtheentirestudyperiodwithinthestandard
Consecutively we selected patients who met the universal, free healthcare for all of the Spanish public
following inclusion criteria: 1) prior diagnosis of COPD ac- system,andthereforewedidnotchangetheregularoffice
cording to GOLD criteria [11]; 2) severe or very severe visits and home calls either by the Pneumologist or the
obstruction to airflow (post-bronchodilator forced expira- Primary Caredoctors.
tory volume (FEV )/forced vital capacity (FVC) < 0.70 and Patients in the control group had no intervention apart
1
FEV %predicted <50%); 3) age older than or equal to 50 from this standard, conventional care, and no other pro-
1
COPDtelemedicine program: PROMETE 457
activeinterventionsduringtheentirestudy.Allinformation transmitthemeasurements.Acontactphonenumberfrom
during the study was collected by visit at the patient’s the CMC was left to the patients for any technical
home except for the satisfaction questionnaire that was problems.
obtained through telephone calls in a blinded fashion in The parameters were collected using the following de-
bothgroups. vices: a spirometer, a pulse-oximeter and heart rate
ThestudywasapprovedbytheEthicsCommitteeofthe monitor(Spirotel(cid:2),MIR),andbloodpressuremonitor(A&D,
HULP, and the study number was 1819. All patients signed model UA-767 BT). Each day after taking these measure-
aninformedconsent formprior to inclusion. ments, data were sent automatically via a modem (Tele-
Modem(cid:3), Aerotel Medical Systems) over the patients’
telephonelines.Furtherdetailscanbefoundintheonline
Study procedures
supplement.
Patients entered the study in a stable situation, being
The PROMETE telehealth program was based on the daily
exacerbation-freeforatleast15days.Entryintothestudy
follow-up of patients with severe COPD at the home by
ofpatientsintheexacerbationphasewaspostponeduntilit
monitoring the following parameters: blood pressure, oxy-
wasover.
gen saturation and heart rate on a daily basis, and peak
Theinformationwasreceived,monitored, assessedand
expiratory flow(PEF) threetimesa week.
followed-up by the CMC through an application that acted
Other TH programs have used similar parameters to
asa trafficlight system:
monitor the patients as: pulsioximetry, blood pressure,
temperature,PEF andspirometry[12e14].
B Green:meantthatmeasurementshadbeentakenand
WechosetousePEFaccordingtoJo´dar-Sa´nchezetal.as
were within the predefined limits, and no further ac-
PEF as it showed more acceptable to being carried out by
tion wasrequired.
the patient [15], and since van de Berge et al. [16] have
B Yellow: “technical alert”. This means that the mea-
linked the fall of percentage of peak-flow with the risk of
surements had not been taken or had not been
COPDexacerbations.
received.Thisalertcouldleadtoa“clinicalalert”due
Measurements were made once a day in the morning,
to a lack of adherence or discouragement. When the
and given the following set of conditions: 20 min after
parameters were not received the nurse at the CMC
medication had been taken, at rest and while on oxygen
calledthe patienttofindthereasonbehindthealert,
therapy. The patients took their measurements on a daily
andeitherruledoutmedicalcausesor,ifone,notified
bases(MondaythroughSunday).MondaythroughFridaythe
the Pneumologist leading the study.
data were monitored and assessed by the Clinical Moni-
B Red: “clinical alert”. Meant that a measurement
toring Center (CMC) from 9:00 to 17:00. And during week-
exceeded the limits that were previously pre-
ends,the dataweredirectlyanalyzed bya Pneumologist.
established for each patient (further details can be
During the recruitment period all patients who were
foundin theonline supplement).
presumed to satisfy the inclusion criteria were consecu-
tivelycontactedbytelephone,untiltherewere30patients
After verification of a Red Flag -Clinical Alert by the
in each group. The purpose of the study was explained to
CMC, a protocolized escalation and clinical response pro-
them,andiftheyagreedtoparticipateanappointmentwas
cedurecommenced.
made fora home visit withthe Pneumologist.
At the first clinical visit the informed consent form was
signed, and data were collected including: gender, age,
Clinical support
level of education, household composition, limitations of
activities of daily living, presence or absence of carer,
Clinical support occurs as a result of the coordination be-
medication,relevantmedicalhistory(Charlsonindex)[17],
tweentheCMC,thePneumologyspecialistandthePrimary
basic physical examination, quality of life questionnaires
Carephysician.
(generic like SF-12, and EuroQol, and disease-specific like
Whenever a Red Flag (clinical alert) was triggered the
SGRQ, and COPD Assessment Test, CAT) [18e20], the Bar-
nurse at the CMC contacted the patient to verify the alert
thel Index [21], and finally the Goldberg questionnaire for
(further details can be found in the online supplement).
anxiety anddepression [22].
When a Red Flag was confirmed, the nurse escalated the
Throughout the duration of the study we collected the
clinical alert to the Pneumologist who then classified the
number of ER visits, hospitalizations, length of hospital
exacerbation as moderate, severe or very severe. For
stay, need for non-invasive ventilation (NIV), and need for
moderateexacerbations,advicetostartmedicaltreatment
admission to ICU forbothgroups.
was given over the telephone; in severe cases, visits were
made to the patient’s home, and in the very severe cases
Patient monitoring and follow-up the patient was advised to come to the emergency room
department(Figs.2and3).
On the first day of the HT programme, monitoring devices As we worked in coordination with each Primary Care
were delivered and installed at the patient’s home by Center, the head of the PCC was alerted when a Red Flag
nursingstaff.Patientsweretrainedintheiroperationandit was detected and, in accordance with our protocol, pa-
wasverifiedthattheywereabletotakeallmeasurements tients with moderate exacerbations who did not improve
properly. Written information was as well given on how to with the prescribed treatment were referred to their cor-
handle/use the monitoring devices, and how to correctly responding PCCfor furtherfollow-up.
458 G.Segrelles Calvo etal.
Patient performeddaily
measurementsat the
Parameters were transmittedvia the
home
telephoneline througha modem
When red flag was detected:
Monitored data
1.-Clinical Monitoring:Center
-Confirmed red flag alert.
-Made clinicqaul estionnai.re Clinical Monitoring Centre
-Escalated alert tothe Pneumologist.
2.-Pneumologist, plannedclinical response: Data not recevied or
No issues Clinical issues
technical issues
-Telephone.
-Went to patient’s home.
Green flag Yellow flag Red flag
-Recomended to go to Emergency
Deparment.
Figure2 TelemonitoringprotocolandClinicalMonitoringCenterfollow-up.
Exacerbation percentages. To measure the relationship between inde-
pendent quantitative variables Student’s t-test was used,
In our study COPD exacerbation was defined as: “an acute and for qualitative variables the Chi2 test was used. The
event” characterized by a worsening of patient’s respira- relationshipbetweentwoqualitativevariablesandrelative
tory symptoms (increased dyspnea, expectoration, puru- risk was obtained through use of contingency tables. Clin-
lentsputum,oranycombinationofthesethreesymptoms) icalfollow-upandmonitoringofbothgroupswasmeasured
that is beyond normal day-to-day variations and leads to
usingKaplaneMeiercurvestoindicatethetimetothefirst
changein medication[11]. contact with the hospital (emergency room visit or hospi-
talization) analysis. Statistical significance was considered
at p< 0.05.
Control group
Given the nature of this pilot study, no formal sample
size was estimated a priori. For convenience and avail-
ThecontrolgroupreceivedConventionalCare.Therewasa
ability, we piloted 30 patients per group, which is reason-
first clinical visit at the home during which baseline data
able number of patients with severe COPD and multiple
were collected for the study and quality of life question-
comorbidities considered to be a representative sample.
naires were completed, and also a visit at the end. Data
The study duration was based upon covering the peak
relating to clinical activity were obtained from the HULP
monthsofmaximumstabilityandnumberofexacerbations
informationsystemandthroughmonthlytelephonecallsto
(December to February) followed by another period of
thepatients.
stability until May. A posteriori, given the differences ob-
For these patients we collected data related to blood
tainedinallprimaryandsecondaryoutcomes,theyshould
pressure, pulsioximetry and heart rate in the first clinical
be considered not only statistically significant but also
visit at home. The baseline of these parameters at the
clinically relevant.
beginningofthestudycomparedwiththeHTgroupisshow
inTable1.
Results
Statistical analysis
Atotalof594patientswereconsideredforrecruitment.Of
For the descriptive analysis we used mean, range, and these, 195 initially met our inclusion criteria and made up
standard deviation for quantitative variables, while quali- the pool of candidates who were contacted and invited to
tativevariableswereexpressedintermsoffrequenciesand participate in the study until 60 patients. The 60
COPDtelemedicine program: PROMETE 459
Red flag
Any measured parameter above set thresholds
Clinical Monitoring Center call to patient
Repeat measurements with telephone assistance
Within normal thresholds?
Yes No
Questionnaire before measurements
Clinical questionnaire
Call to Pneumologist
Checkif patient
Pneumologist
knows how to
perform
measurements
Clinical assessment
Mild/Moderate Very severe
Severe exacerbation
exacerbation exacerbation
Reccommendations Home visit
Referral to ER
by telephone only
Figure3 Step-by-stepprocessafteridentificationofa“Redflag”,classificationofaCOPDexacerbationandresponse.
participantswererecruitedandassignedtothetwogroups: users, although seven of them used it erratically. At the
30patientstotheCCgroupand30patientstotheHTgroup study onset, the mean number of days of clinical stability
(Fig. 1). per year (defined as days with no COPD exacerbation) was
Theirsocio-demographicandclinicalcharacteristicsare 166days,andthemeannumberofhospitalizationswas1.8
shown in Table 1. The mean age was 73.8 years (standard per exacerbationin theprevious year.
deviation (cid:4) 9.5) and 44 patients (74.6%) were men. 62.7% Duringthe7-monthsstudyperiod,weobserveddecrease
ofpatientsreportedhavinganinformalprimarycarer(IPC); inthenumberofemergencyroomvisitsintheHTgroup(20
in 60.5% of the cases this was the spouse, followed by the visits) vs. the CC group (57 visits) (p Z 0.001); number of
patients’ children(15.7%). hospitalizations: HT 12 hospitalizations vs. CC 33 hospital-
The mean Charlson index score was 3.5 (SD (cid:4) 1.9) and izations (p Z 0.015); length of hospital stay: HT 105 days
theaveragenumberofdrugstakenbythepatientsperday vs.CC276days(pZ0.018)andneedforNIV:HT0patients
was8.3(SD(cid:4)2.5).RegardingspecifictreatmentsforCOPD, vs. CC 8 patients (p < 0.0001). We also found that the
the most commonly used bronchodilators werea combina- average number of days to first exacerbation requiring
tion of an inhaled corticosteroid and a long-acting beta- hospitalization was 77.28 days in the CC group and 141.07
adrenergic agonist together with a long-acting muscarinic daysinthe HT group (p Z0.003) (Fig. 4).Fourpatients in
receptors antagonist (Table1). the CC group died (3 of causes related to COPD and1 sec-
AllpatientsinthestudycouldbeclassifiedintogroupD ondarytoaretroperitonealhematoma)vs.twopatients in
asdefinedbytherevised2011GOLDclassification(patients the HT group (1 of causes related to COPD and another
at high risk and with many comorbidities); mean post- secondaryto anintestinal obstruction).
bronchodilatorFEV was39.1%,meanBODEindexwas5.5, We identified a total of 50 Red Flags (clinical alerts),
1
andCATquestionnairewas19.3(moderateimpactonstable from which following our classification system: 39 (78%)
disease).Allpatientswerelong-termhomeoxygentherapy wereclassifiedasmoderate,8(16%)assevere,and3(6%)as
460 G.Segrelles Calvo etal.
Overall, 78% of AECOPD in the HT group were classified
as of a milder severity. In the CC we did not attend the
patient’shomeorperformanyotherplannedintervention,
andfor thisreasonwe areunableto establish the severity
of the AECOPD inthis group.
We did not observe any withdrawals as a result of diffi-
cultiesinusingthedevicesandthetechnology,althoughin
onecasethedatareceivedwerethoseofthecarerandnot
fromthepatient.Theoverallpatientsatisfactionratewas
high (median of telemonitoring time was 72.5%), with the
HTprogrammebeingawardedascoreof9outof10(Fig.5).
The average of telemonitoring days was 152,2 days (72.5%
of the total study time). We defined adherence as the
percentageofthetotaldaysthepatientusedthedevicesto
monitor parameters during the study period. To improve
the adherence each patient was provided with a user
manualforeachdeviceanda“trialrun”wasperformedto
ensure the patient understood the proper functioning of
thesystem.AdditionallytheCMCnursecalledthepatients
who didnottaketheir measurementson a dally bases.
Discussion
The PROMETE study is a novel and innovative home tele-
Figure 4 KeM survival curves of time to the first ER visit/
health program that improved the care of severe COPD
observation/hospitalization,bygroup.
patients. It is the first study conducted in this population
and demonstrated an improvement in many clinical
very severe. Clinical interventions were conducted pri- outcomes.
marily over the telephone (in 37 occasions) or in the pa- The study combines telehealth resources with conven-
tient’s home (in 8 occasions). The main parameters that tional care and early interventions after a detection of an
triggered Red Flags were oxygen saturation (in 30 occa- AECOPDtoimprovethecareofpatientswithsevereCOPD.
sions), followed by peak-flow (in 7 occasions). In 7% (4 oc- The main results of this trial revealed a significant reduc-
casions) of raised “red flag” were due to blood pressure tion in emergency room visits, hospitalizations and length
alteration, though in our study blood pressure had a low of hospital stay of COPD patients enrolled in HT, with
predictivecapacitytoaCOPDexacerbation.Importantly,in equivalent safety and high acceptance for patients
12casesaRedFlagwasnotraisedalthoughthepatienthad receivingCC.
a COPD exacerbation. In the majority of these cases the Our study population was made by COPD patients with
exacerbation occurred out of office hours or during week- severeairflowobstruction(meanFEV 138.9%),onlong-term
ends (5 cases), the parameters received were correct (3 home oxygen therapy, with multiple comorbidities (Charl-
cases), the patient went to the emergency room depart- son index score of 3.57), limitations in activities of daily
ment without being previously monitored and advised (4 living(Barthelindex89.3and64%inneedofacarer),using
cases). multiple medications (average of 8.30 drugs per day) and
46.7% of the HT group reported hospitalizations due to
AECOPDinthepreviousyear.UsingHTfordailymonitoring
andfollow-upallowedustodetectandtreatexacerbations
intheirearlystages.Overall,78%ofAECOPDwereclassified
asmoderateandinterventionswereconductedmainlyover
thetelephone(74%),orashomevisits(5%).Wefocusedon
careatthepatient’shome,initiatingtreatmentforAECOPD
from the home in 80% of the cases. We demonstrated that
HT allows detecting early changes in measurable parame-
tersandthereforeidentifyanAECOPDprematurely.Infact,
we detected more milder exacerbations with HTsince we
were able to monitor daily changes in the patient’s
condition.
In December 2011 the UK Department of Health pub-
lished the results of the “Whole System Demonstrator”
(WSD) program, a randomized clinical trial which involved
6191 patients, 3030 of whom had chronic diseases such as
Figure 5 Patient satisfaction with the Home Telehealth COPD, diabetes mellitus or heart failure, across 3 distant
programattheendoftrial. geographic areas [23]. Health parameters (blood pressure,
COPDtelemedicine program: PROMETE 461
oxygen saturation and temperature) were telemonitored CMC nurse played a key role in filtering the alerts. In this
withadeviceinstalledatthepatients’home.Earlyresults way in clinical alert, AECOPD were differentiated from
showed at reduction of hospitalizations (20%), length of other causes, and were able to detect false positives; And
stay (14%) and time spent in emergency room (14%). The in technical alerts, false negatives were managed by the
implementation of this program was planned to last about CMCnurses,allthisreducingtheburdenofinterventionsby
seven years and the potential maximum benefits were ex- the, as the Pneumologist was only alerted when clinical
pectedtobeachievedinphaseIII(inabout3e4yearsfrom alerts wereconfirmed bythe CMC nurses.
start). We must emphasize that any integrated program for
In a review published in 2010, HTwas shown to reduce COPD care, with or without TH, requires the cooperation
the number of hospitalizations and emergency room visits and coordination between primary and specialist care
incomparisontoCC,althoughtheclinicalcharacteristicsof withinthe community andthe hospital.
thestudiesreviewedwereveryheterogeneous[24].Similar Finally, the main limitations of our study were: 1) the
results were published in a Cochrane review in 2011 [25], smallsamplesize,albeitgiventheseverityofthedisease,
which also found improvement in the quality of life of pa- itwassufficienttoobtainsignificantclinicallyrelevantand
tients. No differences were found in mortality rates; statistically significant differences between the two
possible explanations being that both study groups were groups;2)giventhepoorfunctionalprognosis(COPDGOLD
composedofpatientsintheworstfunctionalclass,whichin stageIVwithmultiplecomorbidities)andonly7monthsof
itself is associated with a poorer prognosis, and the short monitoring period, we were unable to obtain significant
period of follow-up (total of 7 months). All these reports differences in mortality between the two groups; 3) the
concluded that better-designed studies on specific pop- studyfollow-upwaslessthanoneyear;andhencewewere
ulations are needed. To the date, studies in groups of pa- unable to take into account seasonality of AECOPD 3) the
tients with more severe disease are limited to Vitacca’s patient selection could be better; although there were no
work [26] in a population of 240 patients with severe res- withdrawalsbecauseofdifficultiesinusingthedevicesand
piratoryfailure, with a meanFEV of40%. the overall satisfaction rate was high; 4) the lack of indi-
1
With respect to the utility of the telemonitoring pa- vidual randomization, asmentionedabove.
rameters,therearefewstudiesexploringtheutilityofPEF
in COPD patients, especially in these patients without
Future
bronchial hyperactivity. Hurst [12] and van de Berge [16]
linked the fall in the PEF with the probably to detect
early COPD exacerbation. In our study, in 7 occasions PEF Real-lifeeffectivenessandeconomicfeasibilitystudiesare
triggered clinical while oxygen saturation did in 30 occa- needed to implement HT programmes. In addition, larger,
sions, and blood pressure only in 7% of the times (4 multicenter studies and the development of integrated
occasions). care programs within the healthcare system are needed
To sum up the authors concluded that HT programs co- and no more repetitive “pilot projects”. We must improve
ordinated by primary and secondary care groups can the selection process to better identify patients that are
improve the efficient delivery of the health services to mostlikelytobenefitfromTHprograms,definetherolesof
chronic patients due to an easier and more effective thestaffinvolved,andassesstheimpactoftheseprograms
follow-up of chronicpatients. onthe patient’scarer.
In conclusion, the PROMETE study has shown clinical
efficacy in monitoring COPD patients in GOLD group D [11]
Advantages and limitations (severe airflow obstruction, respiratory symptoms, and at-
risk of AECOPD), who also have multiple comorbidities, by
Adherence to the HT program in our trial was good, and reducingthenumberhospitalvisitsthroughearlydetection
there were no withdrawals due to complications of use, and proactive intervention in the patient home before the
although one of the patients had difficulties taking the AECOPD occur. This was possible with the coordination of
measurements, and in the end it was identified that data Primary Care, Pneumologist, and nursing staff. However,
received were those of the carer. This reinforces the we must carefully evaluate the population who meet in-
importanceofselectingpatientswhomaybestbenefitfrom clusion criteria for HT programmes, as the majority of pa-
a TH program [25]. An important aspect for patient tientsareelderly,someofthemwithcognitive,hearing,or
adherencetoaHTistheusedevicesthatarenotdifficultto visual defects that may hinder the continuity of TH on a
use; Finkelstein and Friedman showed that with a short daily basis [28]. Hence, HT programs in severe COPD pa-
training, elderly patients were capable of using a home tients are safe and efficacious in reducing healthcare re-
monitoring system viavideoconference [27]. sources utilization in elderly patients with multiple
Our study did not vary the schedule of the patients’ comorbidities.
appointmentstovisitthePneumologistorPCCs,intervening
onlyiftherewassomechangeinthemonitoredparameters
Conflict of interest statement
thatwererecordeddaily,andtherebyensuringpatientsdid
not lose their relationship with their regular doctors. Co-
ordination with the PCC was essential to maintain conti- All the authors have read the manuscript and have
nuityofcareandtoavoidduplicatingclinicalinterventions approved this submission. Cristina Go´mez-Sua´rez, Ana
andtreatments.Wedealtwithalargeamountofdataand Jorda´n and Elena Tadeo work at Linde Healthcare. The
information, clinical and non-clinical; and in this case the remainingauthors have noconflict ofinterest.
462 G.Segrelles Calvo etal.
ThestudywasapprovedbytheEthicsCommitteeofthe [12] HurstJ,DonaldsonG,QuintJ,GlodringJ,PatelA,WedzichaJ.
HULP, study number was 1819. All patients signed an Domiciliary pulse-oximetry at exacerbation of chronic
informedconsentform priorto inclusion. obstructive pulmonary disease: prospective pilot study. BMC
PulmMed2010;10:52e63.
[13] Franquet J. Home telehealth for patients with chronic
Acknowledgments obstructive pulmonary disease (COPD): an evidence-based
analysis.OntHealthTechnolAssessSer2012;12:1e58.
[14] Koff PB, Jones RH, Cashman JM, Voelkel NF, Vandivier RW.
We thank Linde Healthcare for participating in this study, Proactiveintegratedcareimprovesqualityoflifeinpatients
runningthe CMC andfinancingthe medicalequipment. withCOPD.EurRespirJ2009;33:1031e8.
[15] Jo´dar-Sa´nchez F, Ortega F, Caldero´n CP, Go´mez-Sua´rez C,
Jorda´n A, Pe´rez P, et al. Implementation of a telehealth
programmefor patientswithseverechronicobstructive pul-
Appendix A. Supplementary data
monary disease treated with long-term oxygen therapy. J
TelemedTelecare2013;19:11e7.
Supplementarydatarelatedtothisarticlecanbefoundat [16] van de Berge M, Hop W, van der Molen T, van Noord J,
http://dx.doi.org/10.1016/j.rmed.2013.12.003 Creemers J, Schreurs A, et al. Prediction and course of
symptoms and lung function around an exacerbation in
chronic obstructive pulmonary disease. Respir Res 2012;33:
References 44e53.
[17] Abizanda-Soler P, Paterna-Mellinas G, Mart´ınez-S´anchez E,
Lo´pez-Jime´nez E. Comorbidity in the elderly: utility and
[1] Curry CW, De AK, Ikeda RM, Thacker SB. Health burden and
validity of assessment tools. Rev Esp Gerontol 2010;45:
fundingatthecentersfordiseasecontrolandprevention.Am
219e28.
JPrevMed2006;30:269e76.
[18] Agust´ı A, Soler JJ, Molina J, Mun˜oz MJ, Garc´ıa-Losa M,
[2] YachD,HawkesC,GouldCL,HofmanKJ.Theglobalburdenof
RosetM,JonesPW,BadiaX.IstheCATquestionnairesensitive
chronicdiseases:overcomingimpedimentstopreventionand
tochangesinthehealthstatusinpatientswithsevereCOPD
control.JAMA2004;291:2616e22.
exacerbations?COPD2012;9:492e8.
[3] ChapmanKR,ManninoDM,SorianoJB,VermierePA,BuistAS,
[19] MeguroM,BarleyEA,SpencerS,JonesPW.Developmentand
Thun MJ, Connell C, Jemal A, Lee TA, Miravitlles M,
validation of an improved COPD-specific version of the St.
Aldington S, Beasley R. Epidemiology and costs of chronic
Georgerespiratoryquestionnaire.Chest2007;132:456e63.
obstructivepulmonarydisease.EurRespirJ2006;27:188e207.
[20] Caban˜ero-Mart´ınezMJ,Cabrero-Garc´ıaJ,Richart.Mart´ınezM,
[4] Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ.
Mun˜oz-MendozaCL.TheSpanishversionsoftheBarthelindex
Global and regional burden of disease andrisk factors 2001:
(BI)andtheKatzindex(KI)ofactivitiesofdailyliving(ADL):a
systematic analysis of population health data. Lancet 2006;
structuredreview.ArchGerontolGeriatr2009;49:77e84.
367:1747e57.
[21] GoldbergD,BridgesK,Duncan-JonesP,etal.Detectinganx-
[5] HurstJ,VestboJ,AnzuetoA,LacantoreN,Mu¨llerovaH,Tal-
iety and depression in general medical settings. Br Med J
Singer R, et al. Susceptibility to exacerbation in chronic
1988;97:897e9.
obstructive pulmonary disease. N Engl J Med 2010;363:
[22] Early intervention and for COPD patients. Last accessed in
1128e38.
September2012.Availableat:http://www.commonwell.eu.
[6] Soler-Catalun˜a JJ, Mart´ınez-Garc´ıa MA, Catala´n Serra P.
[23] Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K,
ImpactomultidimensionaldelasexacerbacionesdelaEPOC.
ScottRE.Homeforchronicobstructivepulmonarydisease:a
ArchBronconeumol2010;46:12e9.
systematic review and meta-analysis. J Telemed Telecare
[7] Ancochea J, coordinador cient´ıfico. Estrategia nacional en
2010;16:120e7.
EPOC del Sistema Nacional de Salud. Ministerio Sanidad y
[24] McLean S, Nurmatov U, Liu JLY, Pagliari C, Car J, Sheikh A.
Pol´ıticaSocial;2009.
care for chronic obstructive pulmonary disease. Cochrane
[8] Rabanales-SotoJ,Pa´rragaMart´ınezI,Lo´pez-TorresJ,Andre´s-
DatabaseSystRev2011;7:CD007718.
PretelF,Navarro-BravoB.Tecnolog´ıasdelainformacio´nylas
[25] Vitacca M, Bianchi L, Guerra A, Fracchia C, Spanevello A,
comunicaciones: telemedicina. Rev Clin Med Fam 2011;4:
BalbiB,ScalviniS.Tele-assitanceinchronicrespiratoryfailure
42e8.
patients: a randomised clinical trial. Eur Respir J 2009;33:
[9] Yohannes A. Telehealthcare management for patients with
411e8.
chronicobstructivepulmonarydisease.ExpertRevRespirMed
[26] de Toledo P, Jime´nez S, del Pozo F, Roca J, Alonso A,
2012;6:239e42.
Herna´ndez C. Telemedicine experience for chronic care in
[10] SicotteC,PareG,MorinS,PotvinJ,MoreaultM-P.Effectsof
COPD.IEEETransInfTechnolBiomed2006;10:567e73.
home telemonitoring to support improved care for chronic
[27] Finkelstein J, Friedman RH. Potential role of telecommuni-
obstructivepulmonarydisease.TelemedJE Health2011;17:
cation technologies in the management of chronic health
95e103.
conditions.DisManageHealthOutcome2000;8:57e63.
[11] GOLD.Theglobalinitiativeforchronicobstructivepulmonary
[28] SmithS,ElkinS,PartridgeM.Technologyanditsroleinres-
disease.LastaccessedinJuly2012.Availableat:http://www.
piratorycare.PrimaryCareRespirJ2009;18:159e64.
goldcopd.com;2011.
